https://www.avient.com/idea/quality-design
Documentation supporting relevant product safety and compliance data is available to all customers.
• Declarations based on pre-testing of the ingredients we use to standards typically required for medical and diagnostic devices (biological evaluations ISO10993, USP , for class VI devices); and for pharmaceutical packaging and drug-contacting materials (biological evaluation USP, EP chapter and requirements USP and ICHQ3D extractable metals).
• Letter of Authority (LoA) for our Drug Master File (DMF) and Device Master File (MAF).
• Disclosure of ingredients for purpose of regulatory filings (under specific confidentiality agreements).
https://www.avient.com/investor-center/news/polyone-announces-fourth-quarter-and-full-year-2016-results
In millions, except per share data)
In millions, except per share data)
Condensed Consolidated Balance Sheets
https://www.avient.com/investor-center/news/polyone-announces-fourth-quarter-and-full-year-2017-results
In millions, except per share data)
In millions, except per share data)
Condensed Consolidated Balance Sheets
https://www.avient.com/news/polyone-announces-second-quarter-2014-results
In millions, except per share data)
In millions, except per share data)
Condensed Consolidated Balance Sheets
https://www.avient.com/investor-center/news/avient-announces-third-quarter-2023-results
In millions, except per share data)
In millions, except per share data)
Condensed Consolidated Balance Sheets
https://www.avient.com/investor-center/news/polyone-announces-second-quarter-2017-results
PolyOne Corporation
Condensed Consolidated Statements of Income (Unaudited)
(In millions, except per share data)
PolyOne Corporation
Summary of Special Items (Unaudited)
(In millions, except per share data)
PolyOne Corporation
Condensed Consolidated Balance Sheets
(In millions)
https://www.avient.com/investor-center/news/avient-announces-second-quarter-2024-results
In millions, except per share data)
In millions, except per share data)
Condensed Consolidated Balance Sheets
https://www.avient.com/investor-center/news/avient-announces-fourth-quarter-and-full-year-2020-results-and-provides-guidance-2021
In millions, except per share data)
In millions, except per share data)
Condensed Consolidated Balance Sheets (Unaudited)
https://www.avient.com/investor-center/news/avient-announces-record-second-quarter-2021-results-increases-full-year-guidance
Condensed Consolidated Statements of Income (Unaudited)
(In millions, except per share data)
Summary of Special Items (Unaudited)
(In millions, except per share data)
Condensed Consolidated Balance Sheets
(In millions)
https://www.avient.com/investor-center/news/avient-announces-record-first-quarter-2021-results-increases-full-year-guidance
In millions, except per share data)
In millions, except per share data)
Condensed Consolidated Balance Sheets
